Assessment of Knowledge, Stigmatizing Attitudes and Health-Seeking Behaviors Regarding Hepatitis B Virus Infection in a Pharmacy and Community Setting in Sierra Leone: A Cross-Sectional Study

Hepatitis B virus (HBV) is a major global health challenge. Emerging evidence suggests that poor knowledge and stigma are impacting HBV control efforts in sub-Saharan Africa (SSA), but their role is not well understood. We conducted a cross-sectional study of adults aged ≥18 years in a community and...

Full description

Bibliographic Details
Main Authors: Manal Ghazzawi, Sahr A. Yendewa, Peter B. James, Samuel P. Massaquoi, Lawrence S. Babawo, Foday Sahr, Gibrilla F. Deen, Mustapha Kabba, Ponsiano Ocama, Sulaiman Lakoh, Robert A. Salata, George A. Yendewa
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Healthcare
Subjects:
Online Access:https://www.mdpi.com/2227-9032/11/2/177
Description
Summary:Hepatitis B virus (HBV) is a major global health challenge. Emerging evidence suggests that poor knowledge and stigma are impacting HBV control efforts in sub-Saharan Africa (SSA), but their role is not well understood. We conducted a cross-sectional study of adults aged ≥18 years in a community and pharmacy setting in Freetown, Sierra Leone. A structured questionnaire was used to assess knowledge, stigmatizing attitudes and health-seeking behaviors regarding HBV. Logistic regression was used to identify predictors of HBV knowledge and related stigma. A total of 306 adult participants were enrolled (50.7% male, 7.5% HBV positive and 11.7% vaccinated). Overall, 52.2% had good HBV knowledge and 49.3% expressed a stigmatizing attitude towards people with HBV. Notwithstanding, 72.2% stated they would receive the HBV vaccine if offered, 80.4% would take anti-HBV medication and 78.8% would be willing to attend clinic regularly. Good HBV knowledge was associated with HBV positive status (aOR 4.41; <i>p</i> = 0.029) and being vaccinated against HBV (aOR 3.30; <i>p</i> = 0.034). HBV-related stigma was associated with secondary or higher level of education (aOR 2.36; <i>p</i> < 0.001), good HBV knowledge (aOR 2.05; <i>p</i> = 0.006) and pharmacy setting (aOR 1.74, <i>p</i> = 0.037). These findings suggest that education and stigma reduction may benefit HBV elimination efforts in SSA.
ISSN:2227-9032